Myocardial sympathetic denervation in Chagas' cardiomyopathy: A predictor of deterioration of left ventricular systolic function
- PMID: 34888827
- DOI: 10.1007/s12350-021-02854-w
Myocardial sympathetic denervation in Chagas' cardiomyopathy: A predictor of deterioration of left ventricular systolic function
Comment on
-
Regional myocardial sympathetic denervation precedes the development of left ventricular systolic dysfunction in chronic Chagas' cardiomyopathy.J Nucl Cardiol. 2022 Dec;29(6):3166-3176. doi: 10.1007/s12350-021-02869-3. Epub 2022 Jan 4. J Nucl Cardiol. 2022. PMID: 34981413
References
-
- Freitas HF, Chizzola PR, Paes AT, Lima AC, Mansur AJ. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: Role of Chagas’ heart disease. Int J Cardiol 2005;102:239‐47. - DOI
-
- Morillo CA, Marin-Neto JA, Avezum A, Sosa-Estani S, Rassi A Jr, Rosas F, et al. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. N Engl J Med 2015;373:1295‐306. - DOI
-
- Bocchi EA, Fiorelli A. The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. First Guidelines Group for Heart Transplantation of the Brazilian Society of Cardiology. Ann Thorac Surg 2001;71:1833‐8. - DOI
-
- Hiss FC, Lascala TF, Maciel BC, Marin-Neto JA, Simoes MV. Changes in myocardial perfusion correlate with deterioration of left ventricular systolic function in chronic Chagas’ cardiomyopathy. JACC Cardiovasc Imaging 2009;2:164‐72. - DOI
-
- Simoes MV, Pintya AO, Bromberg-Marin G, Sarabanda AV, Antloga CM, Pazin-Filho A, et al. Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas’ cardiomyopathy. Am J Cardiol 2000;86:975‐81. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources